35 Infos zu Dirk Zboralski

8 Aktuelle Nachrichten

... Idelalisib and Olaptesed Pegol on the Immune Effector Function Mediated by Rituximab Dirk Zboralski, Axel Vater und Anna Kruschinski . Mitarbeiter

Phase-I-Studien mit anti-Hepcidin Spiegelmer ® NOX-H94 Wirkmechanismus des anti-SDF-1/CXCL12 Spiegelmers NOX-A12 bei hämatologischen Krebserkrankungen NOXXON …

The poster presentation, titled “CXCL12 Inhibition with NOX-A12 (Olaptesed Pegol) Increases T and NK Cell Infiltration and Synergizes with Immune Checkpoint Blockade and ADCC in Tumour-Stroma Spheroids,” was shown at the conference by senior scientist Dirk Zboralski and hia colleagues, according ...

Dirk Zboralski, Axel Vater and Anna Kruschinski. Members of NOXXON's drug development team and clinical investigators will be at the ASH ...

1 Profile in Sozialen Netzwerken

Dirk Zboralski. Department of Internal Medicine. Knappschaftskrankenhaus. IMBL , Ruhr-University of Bochum. Bochum. Germany. [. Name/email ...

1 Hobbys & Interessen

... in a 3D Lymphoma ModelAuthors: Dirk Zboralski, Anna Kruschinski, Dirk Eulberg and Axel VaterLocation & time: 58th ASH Annual Meeting, ...

2 Bücher zum Namen

Information about the open-access article 'SDF-1 Inhibition Targets the Bone Marrow Niche for Cancer Therapy' in DOAJ. DOAJ is an online directory that indexes...

The AACR Annual Meeting is a must-attend event for cancer researchers and the broader cancer community. This year's theme, "Delivering Cures Through...

2 Dokumente

Email: Dirk Zboralski - ; Miriam Böckmann - Miriam. ; Marc Zapatka - M.Zapatka@dkfz- heidelberg.de ...

Authors: Sven Klussmann, Frank Schwoebel, Dirk Zboralski, Heather Humphrey, Christian Maasch, Simone Sell, Klaus Buchner, Werner G.

2 Wissenschaftliche Publikationen

Functional loss of the tumor suppressor Smad4 is involved in pancreatic and colorectal carcinogenesis and has been associated with the acquisition of...

The compound olaptesed pegol can stop multiple myeloma from spreading in mouse models, researchers have found, potentially leading to a new approach in...

1 Allgemeine Veröffentlichungen

Search Results: of matches for " Dirk Zboralski " All listed articles are free for downloading (OA Articles) ...

2 Meinungen & Artikel

Seite 1 der Diskussion 'NOXXON - Was kann die Spiegelmer-Technologie?' vom im w:o-Forum 'Biotech'.

16 Webfunde aus dem Netz

Authors: Dirk Zboralski, Anna Kruschinski, Dirk Eulberg and Axel Vater Location & time: ESMO Congress 2016, Copenhagen, Denmark,

Dirk Zboralski, Stefan Zöllner, Anna Kruschinski, Sven Klussmann, Lawrence Recht, and J. Martin Brown. Department of Radiation Oncology, Stanford University, Stanford, CA (S-C.L., R.A., S.B.C., F.L., J.S., J.M.B.); Department of Neurology,. Stanford University, Stanford, CA (T.J., M.M., L.R.,); NOXXON Pharma AG, Berlin, ...

Identification and characterization of a mirror-image oligonucleotide that binds and neutralizes sphingosine 1-phosphate, a central mediator of angiogenesis. Werner G. Purschke, Kai Hoehlig, Klaus Buchner, Dirk Zboralski, Frank Schwoebel, Axel Vater, Sven Klussmann. Biochemical Journal Aug 15, 2014, 462 (1) ; ...

Dirk Zboralski Department of Internal Medicine, Knappschaftskrankenhaus, IMBL, Ruhr University of Bochum, Bochum, Germany BMC Cancer 8: We have reported previously, that Smad4 functions as a positive transcriptional regulator of constitutive and of TGFbeta-induced transcription of all ...

Noxxon Pharma AG, NOXXON Pharma presented updated interim data sets from two independent clinical Phase IIa studies of the anti-CXCL12/SDF…

Berlin, Germany and Boston, USA, Germany December NOXXON Pharma will disclose promising data from two independent clinical Phase IIa

Four posters on NOXXON compounds at the European Hematology Association Congress Berlin, Germany June NOXXON Pharma presented updated

Monday, December 08, 2014, 6:00 PM-8:00 PM, West Building, Level 1 (Moscone Center), Session 625, Publication number: Comparison of Ibrutinib, Idelalisib and Olaptesed Pegol on the Immune Effector Function Mediated by Rituximab Dirk Zboralski, Axel Vater and Anna Kruschinski Members of NOXXON's drug ...

Aldo M. Roccaro, Antonio Sacco, Werner G. Purschke, Michele Moschetta, Klaus Buchner, Christian Maasch, Dirk Zboralski, Stefan Zöllner, Stefan Vonhoff, Yuji ...

Aldo M. Roccaro, Antonio Sacco, Marco Ungari, Patricia Maiso, Salomon Manier, Phong Quang, Yosra Aljaway, Dirk Zboralski, Anna Kruschinski, Fabio Facchetti, Giuseppe Rossi, Irene M. Ghobrial. Members of NOXXON's drug development team and collaboration partners will be at the ASH conference to ...

Julia Hoellenriegel ; Dirk Zboralski ; Christian Maasch ; Nathalie Y. Rosin ; William G. Wierda ; Michael J. Keating ; Anna Kruschinski ; Jan A.

... Marco Ungari, Patricia Maiso, Salomon Manier, Phong Quang, Yosra Aljaway, Dirk Zboralski, Anna Kruschinski, Fabio Facchetti, Giuseppe Rossi, Irene M. Ghobrial. Mitglieder des Arzneimittelentwicklungsteams von NOXXON und Kollaborationspartner werden an der ASH-Konferenz teilnehmen und den ...

BACKGROUND: Functional loss of the tumor suppressor Smad4 is involved in pancreatic and colorectal carcinogenesis and has been associated with the acquisition...

Key Points. The hepcidin inhibitor NOX-H94, a structured mirror-image RNA oligonucleotide, and its in vitro and in vivo characterization are described.First pub